Causes
Bacteria that enter your urinary tract through the tube that carries urine from your body (urethra) can multiply and travel to your kidneys. This is the most common cause of kidney infections.
Bacteria from an infection elsewhere in your body also can spread through your bloodstream to your kidneys. Although it's unusual to develop a kidney infection, it can happen — for instance, if you have an artificial joint or heart valve that becomes infected.
Rarely, kidney infection results after kidney surgery.
Pathophysiology
Acute pyelonephritis results from bacterial invasion of the renal parenchyma. Bacteria usually reach the kidney by ascending from the lower urinary tract. [6] In all age groups, episodes of bacteriuria occur commonly, but most are asymptomatic and do not lead to infection. The development of infection is influenced by bacterial factors and host factors.[7]
Bacteria may also reach the kidney via the bloodstream. Hematogenous sources of gram-positive organisms, such as Staphylococcus, are intravenous drug abuse and endocarditis. Experimental evidence suggests that hematogenous spread of gram-negative organisms to the kidney is less likely unless an underlying problem exists, such as an obstruction. Little or no evidence supports lymphatic spread of uropathogens to the kidney.
Clinical manifestation
Acute pyelonephritis results from bacterial invasion of the renal parenchyma. Bacteria usually reach the kidney by ascending from the lower urinary tract. [6] In all age groups, episodes of bacteriuria occur commonly, but most are asymptomatic and do not lead to infection. The development of infection is influenced by bacterial factors and host factors.[7]
Bacteria may also reach the kidney via the bloodstream. Hematogenous sources of gram-positive organisms, such as Staphylococcus, are intravenous drug abuse and endocarditis. Experimental evidence suggests that hematogenous spread of gram-negative organisms to the kidney is less likely unless an underlying problem exists, such as an obstruction. Little or no evidence supports lymphatic spread of uropathogens to the kidney.
Management
Patients who are systemically unwell will require management in an A to E approach and appropriate resuscitation.
Start empirical antibiotics based on local protocols and IV fluids as appropriate, also prescribing suitable analgesia and anti-emetics. Tailor antibiotic therapy once sensitivities are available.
Whilst many uncomplicated cases can often be treated in the community, consider admission in those cases who are clinically unstable, significant dehydration, or with co-morbidities such as diabetes mellitus, renal transplant graft, immunocompromised.
Severe or non-responding cases may warrant catheterisation and high-dependency unit monitoring, as such cases can becoming profoundly and rapidly unwell. Consider early CT imaging* in such cases to check for obstruction and complications of pyelonephritis, such as of pyonephrosis (infected obstructed kidney) or a perinephric abscess.
Discuss common causes of acute pyelonephritis, and describe the pathophysiology, clinical manifestations, evaluation, and treatment.
Discuss common causes of acute pyelonephritis, and describe the pathophysiology, clinical manifestations, evaluation, and treatment.
Discuss common causes of galactorrhea and describe the pathophysiology, clinical manifestations, evaluation, and treatment of galactorrhea.
Discuss Grave's Disease and the systemic manifestations and treatment of hyperthyroidism. Describe the pathophysiology, clinical manifestations, evaluation, and treatment of hypothyroidism.
Describe the pathophysiology of acute rheumatic fever, and rheumatic heart disease and discuss the pathophysiology, clinical manifestations, evaluation (include the revised Jones Criteria), and treatment of rheumatic fever.
Describe the pathophysiology, clinical manifestations, evaluation, and treatment of tuberculosis or pneumonia.
Describe the pathophysiology, clinical manifestations, evaluation, and treatment of tuberculosis or pneumonia.
Describe childhood acute lymphocytic leukemia (ALL) and G6PD deficiency and the incidence, pathophysiology, clinical manifestations, evaluation, and treatment of each.
Describe the pathophysiology, clinical manifestations, evaluation, and treatment of polycystic ovary syndrome (PC
Discuss the pathophysiology, clinical manifestations, evaluation, and treatment of cystic fibrosis. Discuss the potential impact of gene therapy on CF and the ethical dimensions in treating this life-limiting disease.
Describe the stages of chronic kidney disease, and summarize the pathophysiology, clinical manifestations, evaluation, and treatment.